Posts

December 16, 2014

+
1:03 AM | An Ethics Conference Where an Expert Gets it Wrong
There was an interesting array of topics at last week’s Advancing Ethical Research conference sponsored by Public Responsibility in Medicine and Research (PRIMR), ranging from basics of Institutional Review Boards (IRB) to ethics of Ebola trials, which was excellent. Given my ongoing interest in the Markingson case at the University of Minnesota (UMN) (see below), [...]

December 15, 2014

+
4:46 PM | A Funny Thing Happened on My Way to the Candy Store
If you’re curious about what happened to the daily candy canes over the past few days, here’s the scoop. Starting TODAY, I’m the new Research Evaluation Analyst for the University of Massachusetts Center for Clinical and Translational Science. Yep, I’ve left my former position in the library and venture off into a new world. Since it’s […]

November 29, 2014

+
7:45 AM | This Month in Blastocystis Research (NOV 2014): Blasting Blastocystis Edition
The 'This Month' post is triggered by a paper emerging in the journal Gut Pathogens describing a clinical pilot study on the efficacy of triple antibiotic therapy in Blastocystis positive IBS patients. The article is free for download here. The triple therapy consisted of fourteen days of diloxanide furoate 500 mg thrice daily, trimethoprim/sulfamethoxazole (cotrimoxazole) 160/80 mg twice daily, and secnidazole 400 mg thrice daily. Six of ten patients achieved eradication. […]

Nagel R, Bielefeldt-Ohmann H & Traub R (2014). Clinical pilot study: efficacy of triple antibiotic therapy in Blastocystis positive irritable bowel syndrome patients., Gut pathogens, 6 34. PMID: http://www.ncbi.nlm.nih.gov/pubmed/25349629

Citation
+
7:45 AM | This Month in Blastocystis Research (NOV 2014): Blasting Blastocystis Edition
The 'This Month' post is triggered by a paper emerging in the journal Gut Pathogens describing a clinical pilot study on the efficacy of triple antibiotic therapy in Blastocystis positive IBS patients. The article is free for download here. The triple therapy consisted of fourteen days of diloxanide furoate 500 mg thrice daily, trimethoprim/sulfamethoxazole (cotrimoxazole) 160/80 mg twice daily, and secnidazole 400 mg thrice daily. Six of ten patients achieved eradication. […]

Nagel R, Bielefeldt-Ohmann H & Traub R (2014). Clinical pilot study: efficacy of triple antibiotic therapy in Blastocystis positive irritable bowel syndrome patients., Gut pathogens, 6 34. PMID: http://www.ncbi.nlm.nih.gov/pubmed/25349629

Citation
1
4 Results